Day Three – August 2, 2007 Day One - July 31, 2007       Day Two – August 1, 2007
	CLICK THE ICONS BELOW TO WATCH THE REPLAY WEBCAST OF THIS ENTIRE PLENARY SESSION IV REPLAY Click Here For Technical Support 8:00 - 8:10am     WELCOME Carol D. Linden, Ph.D. Principal Deputy Director and Acting Director, Office of Biomedical Advanced Research and Development Authority Office of the Assistant Secretary for Preparedness and Response, Department of Health and Human Services 8:10 - 8:25am MEDICAL COUNTERMEASURE RESEARCH AND DEVELOPMENT PIPELINE - CBRN THREATS Michael Kurilla, M.D., Ph.D. Director, Office of Biodefense Research Activities, Division of Microbiology and Infectious Diseases Associate Director for Biodefense Product Development, National Institute of Allergy and Infectious Diseases National Institutes of Health, Department of Health and Human Services 8:25 - 8:40am MEDICAL COUNTERMEASURE RESEARCH AND DEVELOPMENT PIPELINE - PANDEMIC INFLUENZA Carole Heilman, Ph.D. Director, Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases National Institutes of Health, Department of Health and Human Services 8:40 - 8:55am DEPARTMENT OF DEFENSE TRANSFORMATIONAL MEDICAL TECHNOLOGIES INITIATIVE (TMTI) COL David G. Jarrett, MC, USA Deputy Special Assistant and Medical Director, Chemical Biological Defense Programs Department of Defense 8:55 - 9:10am ANIMAL MODEL DEVELOPMENT Judith Hewitt, Ph.D. Research Resources Program Officer, National Institute of Allergy and Infectious Diseases National Institutes of Health, Department of Health and Human Services 9:10 - 9:25am HHS CBRN MEDICAL COUNTERMEASURE ACQUISITIONS - A FORECAST Monique K. Mansoura, Ph.D Acting Deputy Director for Policy, Planning, and Requirements Office of Biomedical Advanced Research and Development Authority Office of the Assistant Secretary for Preparedness and Response, Department of Health and Human Services 9:25 - 9:40am PANDEMIC INFLUENZA PHARMACEUTICAL AND NON-PHARMACEUTICAL MEDICAL COUNTERMEASURE ACQUISITIONS - A FORECAST Robin Robinson, Ph.D Acting Associate Director, Office of Biomedical Advanced Research and Development Authority Office of the Assistant Secretary for Preparedness and Response. Department of Health and Human Services 9:40 - 10:00am Q AND A
BREAK     10:00 - 10:20     Ballroom Foyer
	CLICK THE ICONS BELOW TO WATCH THE REPLAY WEBCAST OF THIS ENTIRE SEMINAR SESSION IV REPLAY Click Here For Technical Support 10:20 - 10:40am     Indemnification/Liability Protections under the Public Readiness and Emergency Preparedness (PREP) Act Dan Barry, J.D. Deputy Associate General Counsel, Office of the General Counsel, Department of Health and Human Services 10:40 - 11:00am Intellectual Property Issues in Medical Countermeasure Development Julie A. Muroff, J.D. Senior Attorney, Office of the General Counsel, Public Health Division National Institutes of Health Branch, Department of Health and Human Services 11:00 - 11:20am New Provisions under BARDA Michael Goulding, J.D. Attorney, Office of the General Counsel, Department of Health and Human Services 11:20 - 11:30am Q and A
LUNCH ON YOUR OWN     11:30AM - 1:00PM
	CLICK THE ICONS BELOW TO WATCH THE REPLAY WEBCAST OF THIS ENTIRE PLENARY SESSION V REPLAY Click Here For Technical Support 1:00 - 1:20pm     NATIONAL RESPONSE PLANNING (EMERGENCY SUPPORT FUNCTION-8) Kevin Yeskey, M.D. Deputy Assistant Secretary and Director, Office of Preparedness and Emergency Operations Office of the Assistant Secretary for Preparedness and Response, Department of Health and Human Services 1:20 - 1:35pm CBRN MEDICAL COUNTERMEASURES IN FEDERAL RESPONSE PLANNING CAPT Ann Knebel, R.N., D.N.Sc., F.A.A.N. Deputy Director for Preparedness Planning, Office of Preparedness and Emergency Operations Office of the Assistant Secretary for Preparedness and Response, Department of Health and Human Services 1:35 - 1:50pm PANDEMIC INFLUENZA MEDICAL COUNTERMEASURES IN FEDERAL RESPONSE PLANNING Keith Holtermann, Dr.P.H., M.B.A., M.P.H., R.N. Office of Preparedness and Emergency Operations Office of the Assistant Secretary for Preparedness and Response, Department of Health and Human Services 1:50 - 2:05pm STRATEGIC NATIONAL STOCKPILE UTILIZATION AND DEPLOYMENT Greg Burel Acting Director, Division of Strategic National Stockpile Centers for Disease Control and Prevention, Department of Health and Human Services 2:05 - 2:20pm FEDERAL COOPERATION WITH STATE, LOCAL, AND TRIBAL RESPONSE Christa Singleton, M.D., M.P.H. Associate Director for Science, Division of State and Local Readiness Centers for Disease Control and Prevention, Department of Health and Human Services 2:20 - 2:30pm Q AND A
BREAK     2:30 - 2:45     Ballroom Foyer
	CLICK THE ICONS BELOW TO WATCH THE REPLAY WEBCAST OF THIS ENTIRE CLOSING SESSION REPLAY Click Here For Technical Support 2:45 - 3:05 pm     MEDICAL COUNTERMEASURE DEVELOPMENT AND ACQUISITION: THE PATH FORWARD UNDER THE HHS PANDEMIC INFLUENZA PLAN Benjamin Schwartz, M.D. Senior Science Advisor, National Vaccine Program Office, Department of Health and Human Services 3:05 - 3:30 pm MEDICAL COUNTERMEASURE DEVELOPMENT AND ACQUISITION: THE PATH FORWARD UNDER THE HHS PHEMCE IMPLEMENTATION PLAN FOR CBRN THREATS Carol D. Linden, Ph.D. Principal Deputy Director and Acting Director, Office of Biomedical Advanced Research and Development Authority Office of the Assistant Secretary for Preparedness and Response, Department of Health and Human Services
back to top